MGMT and neoplasm: The elevated tumor mutational burden of 15 mutations/megabase, may suggest these tumors have increased levels of tumor neoantigens and therefore more immunogenic, which could be due to impaired DNA repair in the setting of MGMT promoter hypermethylation.